4 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow ALKS-33: new trials by email Literature Review of ALKS-33 trials Research Report on ALKS-33
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder RDC-0313 (ALKS 33), Placebo - Binge Eating Disorder | Phase 2 | Completed | Alkermes, Inc. | 69 | 2010-05-01 | 2011-08-23 |
| Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults RDC-0313 + Buprenorphine, Placebo - Substance-Related Disorders | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 12 | 2010-01-01 | 2017-01-11 |
| ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence ALKS33 (RDC-0313) (1 mg), ALKS33 (RDC-0313) (2.5 mg), ALKS33 (RDC-0313) (10 mg) - Alcohol Dependence | Phase 2 | Completed | Alkermes, Inc. | 406 | 2009-10-01 | 2011-08-23 |
| ALK33-001: A Study of RDC-0313 Administered to Healthy Adults RDC-0313, Placebo - Alcohol Dependence | Phase 1 | Completed | Alkermes, Inc. | 16 | 2008-12-01 | 2011-08-22 |
Alcoholism (2) · Binge-Eating Disorder (1) · Substance-Related Disorders (1)
Alkermes, Inc. (3) · National Institute on Drug Abuse (NIDA) (1)
United States (4)